Loading
AMEXHealthcareBiotechnology
Latest quote
$5.02
−$0.49 · -8.89%
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
Previous close
$5.02
−$0.49 · -8.89%
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
25
Expensive
Sentiment
51
Mixed
Risk
66
High Risk
Momentum
19
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
Day range
Current $5.02
52-week range
Current $5.02
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of goods sold | 5.71K USD | — | — | — | — |
| Gross profit | −5.71K USD | — | — | — | — |
| Research and development | 1.63M USD | — | 98.54K USD | 368K USD | 489.94K USD |
| Selling, general, and administrative | 10.27M USD | 1.28M USD | 648.89K USD | 271.53K USD | 529.56K USD |
| Operating expenses | 11.91M USD | 1.28M USD | 747.44K USD | 639.53K USD | 1.02M USD |
| Interest income | 107.6K USD | 2.82K USD | 7.81K USD | — | — |
| Interest expense | 283.01K USD | 117.72K USD | 38.07K USD | 29.14K USD | 6.74K USD |
| Depreciation and amortization | 5.71K USD | — | — | — | — |
| Operating income | −11.91M USD | −1.28M USD | −747.44K USD | −639.53K USD | −1.02M USD |
| Net income | −6M USD | −1.39M USD | −777.69K USD | −668.67K USD | −1.03M USD |
Company facts updated Oct 10, 2026.
Recent quarterly results
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.